Cardiovascular diseases and sleep-disordered breathing;Herz-kreislauferkrankungen und schlafbezogene obstruktive atmungsstörungen

Pneumologie

Volumn 58, Issue 7, 2004, Pages 505-509

  Hein, H ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

AGE DISTRIBUTION; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DISEASE COURSE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOXEMIA; INSULIN SENSITIVITY; MICROCIRCULATION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; POPULATION RESEARCH; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; STRESS; SYMPATHETIC TONE;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL ADHESION MOLECULES; HUMANS; INTERLEUKINS; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 3943086211     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818532     Document Type: Review

References (72)

1. Ohayon MM, Guilleminault C, Paiva T et al. An international study on sleep disorders in the general population: methodological aspects of the use of the Sleep-EVAL system. Sleep 1997; 20: 1086-1092
2. Young T, Palta M, Dempsey J et al. The occurence of sleep-disordered breathing among middle-aged adults. New Engl J Med 1993; 328: 1230-1235
3. American Sleep Disorders Association. EEC Arousals: scoring rules and examples. Sleep 1992; 15: 174-184
4. Guilleminault C, Hoed J van den, Mitler MM. Clinical overview of the sleep apnea syndromes. In: Guilleminault C, Dement WE (Hrsg.). Sleep apnea syndromes. New York: Alan R Viss, 1978
5. Guilleminault C, Elridge FL, Dement WC. Insomnia with sleep apnea: a new syndrome. Science 1973; 181: 856-858
6. Duchna HW, Grote L, Andreas S et al. Sleep-Disordered breathing and cardio- and cerebrovascular diseases: 2003 update of clinical significance and future perspectives. Somnology 2003; 3: 101-121
7. Shamsuzzaman AS, Gersh BJ, Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003; 290: 1906-1914
8. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003; 108: 9-12
9. Lugaresi E, Coccagna C, Cirignotta F et al. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 1980; 3: 221-224
10. Smith R, Ronald J, Delaive K et al. What are Obstructive Sleep Apnea Patients Being Treated for Prior to This Diagnosis? Chest 2002; 121: 164-172
11. Chaouat A et al. Association of chronic-obstructive pulmonary disease and sleep apnoea syndrome. AJRCCM 1995; 151: 82-86
12. Sanders MH et al. Sleep and Sleep-disordered Breathing in Adults with Predominantly Mild Obstructive Airway Disease. AJRCCM 2003; 167: 7-14
13. Hung J, Whitford E, Parsons R et al. Association of sleep apnoea with myocardial infarction in men. Lancet 1990; 336: 261-264
14. Bassetti C, Aldrich MS. Sleep Apnea in Acute Cerebrovascular Diseases: Final Report on 128 Patients. Sleep 1999; 22: 217-223
15. Peker Y, Hedner J, Kraiczi H et al. Respiratory disturbance index. An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-86
16. Baruzzi A, Riva R, Cirignotta F et al. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep 1991; 14: 83-86
17. Hedner J, Darpö B, Ejnell H et al. Reduction in sympathetic activity after long-term treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995; 8: 222-229
18. Ziegler MG, Nelesen R, Mills P et al. Sleep Apnea, Norepinephrine-Release Rate, and Daytime Hypertension. Sleep 1997; 20: 224-231
19. Solin P, Kaye DM, Little PJ et al. Impact of Sleep Apnea on Sympathetic Nervous System Activity in Heart Failure. Chest 2003; 123: 1119-1126
20. Narkiewicz K, Borne P van de, Montano N et al. Contribution of Tonic Chemoreflex Activation to Sympathetic Activity and Blood Pressure in Patients with Obstructive Sleep Apnea. Circulation 1998; 97: 943-945
21. Narkiewicz K, Montano N, Cogliati C et al. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-1077
22. Imadojemu VA, Gleeson K, Quraishi SA et al. Impaired Vasodilator Responses in Obstructive Sleep Apnea Are Improved with Continuous Positive Airway Pressure Therapy. Am J Respir Crit Care Med 2002; 165: 61-66
23. Heindl S, Lehnert M, Criee CP et al. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164: 597-601
24. Heitmann J, Ehlenz K, Penzel T et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23: 255-262
25. Duchna HW, Guilleminault C, Stoohs RA et al. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000; 161: 187-191
26. Ip MSM, Tse H, Lam B et al. Endothelial Function in Obstructive Sleep Apnea and Response to Treatment. Am J Respir Crit Care Med 2004; 169: 348-353
27. Ip MSM, Lam B, Chan LY et al. Circulating Nitric Oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000; 162: 2166-2171
28. Schulz R, Schmidt D, Blum A et al. Decreased plasma levels of nitric oxide derivates in obstructive sleep apnoea: response to CPAP therapy. Thorax 2000; 55: 1046-1051
29. Schulz R, Mahmoudi S, Hattar K et al. Enhanced Release of Superoxide from Polymorphonuclear Neutrophils in Obstructive Sleep Apnea. Am J Respir Crit Care Med 2000; 162: 566-570
30. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecule expression and production of of reactive oxygen species in leucocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939
31. Barcelo A, Miralles C, Barbe F et al. Abnormal lipid peroxidation in patients with sleep apnoea. Eur Respir J 2000; 16: 644-647
32. Lavie L, Vishnevsky A, Lavie P. Evidence for Lipid Peroxidation in Obstructive Sleep Apnea. Sleep 2004; 27: 123-128
33. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002; 165: 934-939
34. Ridker PM. High-Sensitivity C-Reactive Protein. Potential Adjunct for Global Risk Assessment the Primary Prevention of Cardiovascular Disease. Circulation 2001; 103: 1813-1818
35. Yokoe T, Minoguchi K, Matsuo H et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107: 1129-1134
36. Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 2003; 168: 242-249
37. Schulz R, Hummel C, Heinemann S et al. Serum Levels of Vascular Endothelial Growth Factor Are Elevated in Patients with Obstructive Sleep Apnea and Severe Nighttime Hypoxia. Am J Respir Crit Care Med 2002; 165: 67-70
38. Lavie L, Kraiczi H, Hefetz A et al. Plasma Vascular Endothelial Growth Factor in Sleep Panea Syndrome. Am J Respir Crit Care Med 2002; 165: 1624-1628
39. Ohga E, Nagase T, Tomita T et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999; 87: 10-14
40. Suzuki T, Nakano H, Maekawa J et al. Obstructive Sleep Apnea and Carotid-Artery Intima-Media Thickness. Sleep 2004; 27: 129-133
41. Nieto FJ, Herrington DM, Redline S et al. Sleep Apnea and Markers of Vascular Endothelial Function in a Large Community Sample of Older Adults. Am J Respir Crit Care Med 2004; 169: 354-360
42. Duchna HW, Guilleminault C, Stoohs RA et al. Vascular reactivity in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2000; 161: 187-191
43. Imadojemu VA, Gleeson K, Gray KS et al. Obstructive Apnea during Sleep is Associated with Peripheral Vasoconstriction. Am J Respir Crit Care Med 2002; 165: 950-953
44. Ip MS, Lam KS, Ho C et al. Serum Leptin and Vascular Risk Factors in Obstructive Sleep Apnea. Chest 2000; 118: 580-586
45. Ip MSM, Lam B, Ng MMT et al. Obstructive sleep apnea is indepedently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-676
46. Punjabi NM, Sorkin JD, Katzel LI et al. Sleep disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-682
47. Börntop P. Metabolic implications of body fat distribution. Diab Care 1991; 14: 1132-1143
48. Harsch IA, Schahin SP, Radespiel-Troger M et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004; 169: 156-162
49. Wessendorf TE, Thilmann A, Wang YM et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000; 162: 2039-2042
50. Steiner S, Evers S, Heidland UE et al. Plasma viscosity and fibrinogen in obstructive sleep apnea. Sleep Med 2003; 4S1: S44
51. Chin K, Ohi M, Kita H et al. Effects of NCPAP-Therapy on Fibrinogen Levels in Obstructive Sleep Apnea Syndrome. Am J Respir Crit Care Med 1996; 153: 1972-1976
52. Sanner BM, Konermann M, Tepel M et al. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000; 16: 648-652
53. Davies CWH, Crosby JH, Mullins RL et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000; 55: 736-740
54. Grote L, Ploch T, Heitmann J et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999; 160: 1875-1882
55. Morrell MJ, Finn L, Kim H et al. Sleep Fragmentation, Awake Blood Pressure and Sleep-Disordered Breathing in a Population-based Study. Am J Respir Crit Care Med 2000; 162: 2091-2096
56. Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829-1836
57. Peppard PE, Young T, Palta M et al. Propspective study of the association between sleep-disordered breathing and hypertension. New Engl J Med 2000; 342: 1378-1384
58. Sullivan CE, Berthon-Jones M, Issa FG et al. Reversal of obstructive sleep apnoea by continous positive airway pressure applied through the nares. Lancet 1981; 1: 862-865
59. Becker HF, Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73
60. He J, Kryger MH, Zorick FJ et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385-male patients. Chest 1988; 94: 9-14
61. Partinen M, Guilleminault C. Daytime sleepiness and vascular morbidity at seven-year follow-up in obstructive sleep apnea patients. Chest 1990; 97: 27-32
62. Mooe T, Franklin KA, Holmström K et al. Sleep-Disorderd Breathing and Coronary Artery Disease. Am J Respir Crit Care Med 2001; 164: 1910-1913
63. Marti S, Sampol G, Munoz X et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20: 1511-1518
64. Peker Y, Hedner J, Norum J et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166: 159-165
65. Mooe T, Franklin K, Wiklund U et al. Sleep disordered breathing in patients with coronary artery disease. Chest 2000; 117: 1597-1602
66. Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleepapnea. N Engl J Med 2003; 348: 1233-1241
67. Heindl S, Dodt C, Krahwinkel M et al. Short term effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure. Heart 2001; 85: 185-190
68. Mansfield DR, Gollogly NC, Kaye DM et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169: 361-366
69. Fichter J, Bauer D, Arampatzis S et al. Sleep-related breathing disorders are associated with ventricular arrhythmias in apteints with an implantable cardioverter defibrillator. Chest 2002; 122: 558-561
70. Kamba M, Suto Y, Ohta Y et al. Cerebral Metabolism in Sleep Apnea. Am J Respir Crit Care Med 1997; 156: 296-298
71. Palomaki H. Snoring and the risk of ischemic brain infarction. Stroke 1991; 22: 1021-1025
72. Dyken ME, Somers VK, Yamada T et al. Investigating the relationsship between stroke and obstructive sleep apnea. Stroke 1996; 27: 401-407